Serum levels of platelet-derived growth factor BB homodimers are increased in male children with autism

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 1, 2010, Pages 154-158

  Kajizuka, Masanobu ^a   Miyachi, Taishi ^a   Matsuzaki, Hideo ^a,b   Iwata, Keiko ^a   Shinmura, Chie ^a   Suzuki, Katsuaki ^a   Suda, Shiro ^a   Tsuchiya, Kenji J ^a   Matsumoto, Kaori ^a   Iwata, Yasuhide ^a   Nakamura, Kazuhiko ^a   Tsujii, Masatsugu ^a,c   Sugiyama, Toshiro ^d   Takei, Nori ^a   Mori, Norio ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c CHUKYO UNIVERSITY   (Japan)

^d AICHI CHILDREN'S HEALTH AND MEDICAL CENTER   (Japan)

Author keywords

Autism; ELISA; Human serum; Platelet derived growth factor; Vascular endothelial growth factor

Indexed keywords

HOMODIMER; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR BB; VASCULOTROPIN;

ADOLESCENT; ADULT; ARTICLE; AUSTISM DIAGNOSYIC INTERVIEW; AUTISM; BLOOD ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INTELLIGENCE QUOTIENT; MALE; PATHOPHYSIOLOGY; PSYCHOLOGIC TEST; WECHSLER INTELLIGENCE SCALE;

ADOLESCENT; AUTISTIC DISORDER; CASE-CONTROL STUDIES; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LINEAR MODELS; MALE; PLATELET-DERIVED GROWTH FACTOR; PROTEIN STRUCTURE, TERTIARY; PSYCHIATRIC STATUS RATING SCALES; SERUM; SEVERITY OF ILLNESS INDEX; STEREOTYPED BEHAVIOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 73649135323     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.10.017     Document Type: Article

References (54)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Press, Washington, D.C
2. Ashwood P., Anthony A., Pellicer A.A., Torrente F., Wakefield J.A., and Walker-Smith A.J. Intestinal lymphocyte populations in children with regressive autism, evidence for extensive mucosal immunopathology. J Clin Immunol 23 (2003) 504-517
3. Baron-Cohen S., and Belmonte M.K. Autism: a window onto the development of the social and the analytic brain. Annu Rev Neurosci 28 (2005) 109-126
4. Bartholdi D., Rubin B.P., and Schwab M.E. VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat. Eur J NeuroSci 9 (1997) 2549-2560
5. Basu S., Nagy J.A., Pal S., Vasile E., Eckelhoefer V., Bliss S., et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med 7 (2001) 569-574
6. Battegay E.J., Raines E.W., Colbert T., and Ross R. TNF-alpha stimulation of fibroblast proliferation. Dependence on platelet-derived growth factor (PDGF) secretion and alteration of PDGF receptor expression. J Immunol 154 (1995) 6040-6047
7. Belmonte M.K., Belmonte G.A., Beckel-Mitchener A., Boulanger L.M., Carper R.A., and Webb S.J. Autism and abnormal development of brain connectivity. J Neurosci 24 (2004) 9228-9231
8. Betsholtz C., Johnsson A., Heldin C.H., Westermark B., Lind P., Urdea M.S., et al. cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature 320 6064 (1986) 695-699
9. Cohly H.H., and Panja A. Immunological findings in autism. Int Rev Neurobiol 71 (2005) 317-341
10. Croonenberghs J., Bosmans E., Deboutte D., Kenis G., and Maes M. Activation of the inflammatory response system in autism. Neuropsychobiology 45 (2002) 1-6
11. Dasgupta P.S., and Lahiri T. Antitumor effect of i.p.dopamine in mice bearing Ehrlich ascites carcinoma. J Cancer Res Clin Oncol 113 (1987) 363-368
12. Egan M.F., and Weinberger D.R. Neurobiology of schizophrenia. Curr Opin Neurobiol 7 (1997) 701-707
13. Fatemi S.H., Realmuto G.M., Khan L., and Thuras P. Fluoxetine in treatment of adolescent patients with autism, a longitudinal open trial. J Autism Dev Disord 28 4 (1998) 303-307
14. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 6 (2003) 669-676
15. Fredriksson L., Li H., and Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev 15 4 (2004) 197-204
16. Furlano R.I., Anthony A., Day R., Brown A., McGarvey L., Thomson M.A., et al. Colonic CD8 and γδT-cell infiltration with epithelial damage in children with autism. J Pediatr 138 (2001) 366-372
17. Geschwind D.H., and Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol 17 1 (2007) 103-111
18. Goppelt-Struebe M., and Stroebel M. Synergistic induction of monocyte chemoattractant protein-1 (MCP-1) by platelet-derived growth factor and interleukin-1. FEBS Lett 374 3 (1995) 375-378
19. Greenberg D.A., and Jin K. From angiogenesis to neuropathology. Nature 438 7070 (2005) 954-959
20. Hashimoto K., Iwata Y., Nakamura K., Tsujii M., Tsuchiya K.J., Sekine Y., et al. Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006) 1529-1531
21. Heldin C.H., and Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79 4 (1999) 1283-1316
22. Heldin C.H., Johnsson A., Wennergren S., Wernstedt C., Betsholtz C., and Westermark B. A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains. Nature 319 6053 (1986) 511-514
23. Ishibashi M., Fujisawa M., Furue H., Maeda Y., Fukayama M., and Yamaji T. Inhibition of growth of human small cell lung cancer by bromocriptine. Cancer Res 54 (1994) 3442-3446
24. Johnsson A., Heldin C.H., Westermark B., and Wasteson A. Platelet-derived growth factor: identification of constituent polypeptide chains. Biochem Biophys Res Commun 104 1 (1982) 66-74
25. Jyonouchi H., Sun S., and Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology 46 (2002) 76-84
26. Jyonouchi H., Geng L., Ruby A., and Zimmerman-Bier B. Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 51 (2005) 77-85
27. Kalkanis S.N., Carroll R.S., Zhang J., Zamani A.A., and Black P.M. Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas. J Neurosurg 85 (1996) 1095-1101
28. Kerbel R.S. Tumor angiogenesis. N Engl J Med 358 19 (2008) 2039-2049
29. Kohler N., and Lipton A. Platelets as a source of fibroblast growth-promoting activity. Exp Cell Res 87 2 (1974) 297-301
30. Krzystek-Korpacka M., Neubauer K., Matusiewicz M. Platelet-derived growth factor (PDGF)-BB reflects clinical, inflammatory and angiogenic disease activity and oxidative stress in inflammatory bowel disease. Clin Biochem 2009;42(16-17):1602-9.
31. Lambrechts D., and Carmeliet P. VEGF at the neurovascular interface: therapeutic implications for motor neuron disease. Biochim Biophys Acta 1762 11-12 (2006) 1109-1121
32. Levitt P., Eagleson K.L., and Powell E.M. Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends Neurosci 27 (2004) 400-406
33. Lewis D.A., and Liebermann J.A. Catching up on schizophrenia: natural history and neurobiology. Neuron 28 (2000) 325-334
34. Lewis M.H., Bodfish J.W., Powell S.B., and Golden R.N. Clomipramine treatment for stereotype and related repetitive movement disorders associated with mental retardation. Am J Ment Retard 100 (1995) 299-312
35. Lord C., Rutter M., and Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24 (1994) 659-685
36. Lord C., Cook E.H., Leventhal B.L., and Amaral D.G. Autism spectrum disorders. Neuron 28 (2000) 355-363
37. Matsuzaki H., Tamatani M., Yamaguchi A., Namikawa K., Kiyama H., Vitek M.P., et al. Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades. FASEB J 5 (2001) 1218-1220
38. Ment L.R., Stewart W.B., Fronc R., Seashore C., Mahooti S., Scaramuzzino D., et al. Vascular endothelial growth factor mediates reactive angiogenesis in the postnatal developing brain. Dev Brain Res 100 (1997) 52-61
39. Monacci W.T., Merrill M.J., and Oldfield E.H. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 264 (1993) C995-C1002
40. Okada K., Hashimoto K., Iwata Y., Nakamura K., Tsujii M., Tsuchiya K.J., et al. Decreased serum levels of transforming growth factor-beta1 in patients with autism. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 187-190
41. Rosenstein J.M., and Krum J.M. New roles for VEGF in nervous tissue-beyond blood vessels. Exp Neurol 187 2 (2004) 246-253
42. Schoenecker B., and Heller K.E. The involvement of dopamine (DA) and serotonin (5-HT) in stress-induced stereotypies in bank voles (Clethrionomys glareolus). Appl Anim Behav Sci 73 4 (2001) 311-319
43. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1 (1987) 133-152
44. Sugihara G., Hashimoto K., Iwata Y., Nakamura K., Tsujii M., Tsuchiya K.J., et al. Decreased serum levels of hepatocyte growth factor in male adults with high-functioning autism. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 412-415
45. Suzuki K., Hashimoto K., Iwata Y., Nakamura K., Tsujii M., Tsuchiya K.J., et al. Decreased serum levels of epidermal growth factor in adult subjects with high-functioning autism. Biol Psychiatry 62 (2007) 267-269
46. Teunis M.A.T., Kavelaars A., Voest E., Bakker J.M., Ellenbroek B.A., Cools A.R., et al. Reduced tumor growth, experimental metastasis formation, and angiogenesis in rats with a hyperreactive dopaminergic system. FASEB J 16 11 (2002) 1465-1467
47. Torrente F., Ashwood P., Day R., Machado N., Furlano R.I., Anthony A., et al. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry 7 (2002) 375-382
48. Valicenti-McDermott M., McVicar K., Rapin I., Wershil B.K., Cohen H., and Shinnar S. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr 27 Suppl 2 (2006) S128-S136
49. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., and Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57 (2005) 67-81
50. Volkmar F.R., and Pauls D. Autism. Lancet 362 (2003) 1133-1141
51. Wakefield A.J., Murch S.H., Anthony A., Linnell J., Casson D.M., Malik M., et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351 (1998) 637-641
52. Wakefield A.J., Anthony A., Murch S.H., Thomson M., Montgomery S.M., Davies S., et al. Enterocolitis in children with developmental disorders. Am J Gastroenterol 95 (2000) 2285-2295
53. Waterfield M.D., Scrace G.T., Whittle N., Stroobant P., Johnsson A., Wasteson A., et al. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature 304 5921 (1983) 35-39
54. Westermark B., and Wasteson A. A platelet factor stimulating human normal glial cells. Exp Cell Res 98 1 (1976) 170-174